Business Wire

Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded ...

NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (“Revelation”), a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention ...
Business Wire

Global Upper Respiratory Tract Infection Treatment Market 2019-2023 | Evolving Opportunities with GlaxoSmithKline Plc and Merck & Co., Inc. | Technavio

LONDON--(BUSINESS WIRE)--The global upper respiratory tract infection (URTI) treatment market is expected to grow by USD 1.98 billion during 2019-2023, progressing at a CAGR of almost 4% during the ...
Officer

Infection Control Management System

Agisent's comprehensive Infection Control management system includes automated Infectious Contact form generation and a dedicated real-time portal for Infection Control Officers. This lets the ICO ...